(PharmaNewsWire.Com, June 20, 2017 ) Antivirals are used to treat infections caused by viruses. Unlike antibacterial drugs, which may cover a wide range ofpathogens, antiviral agents tend to be narrow in spectrum, and have limited efficacy.
Exclusive of the antiretroviral agents used in HIV (AIDS) therapy, there are currently only 11 antiviral drugs available,covering four types of virus. Acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex)are effective againstherpesvirus, including herpes zoster and herpes genitalis. They may also be of value in either conditions caused byherpes, such as chickenpox and shingles. These drugs are not curative, but may reduce the pain of a herpes outbreakand shorten the period of viral shedding.
Amantadine (Symmetrel), oseltamivir (Tamiflu), rimantidine (Flumadine), and zanamivir (Relenza) are useful in treatmentof influenza virus. Amantadine, rimantadine, and oseltamivir may be administered throughout the flu season aspreventatives for patients who cannot take influenza virus vaccine.
The report also presents detailed analysis of multitude of factors affecting the Antiviral Drugs market bearing either positive or negative outcomes. Some of those factors are:
• Increased public awareness • Rise in healthcare expenditure • Introduction of new and innovative products • Increase in viral infection incidences • Increasing diseased population • Rising demand for antiviral drugs • High cost involved in drug development • Increase in demand for alternative medicines such as naturopathy, homeopathy, and oriental medicines among others • Majority of population, especially in India and China relying on traditional medicines for treating flu like cold, cough and viral fever.
For granular level understanding the Antiviral Drugs Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. Asia-Pacific Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers.
On the basis of geography, the Asia-pacific Antiviral drugs market is segmented into the countries China, India, Japan, and South Korea. The Antiviral drugs market in Asia-Pacific is the fastest growing followed by Latin America.
The major companies dominating the Antiviral Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
The Asia-Pacific Antiviral Drugs Market report offers wide-range of scope: • Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries • Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations • Detailed explanation of major drivers, restraints, opportunities, and challenges(DROC) that affect the market and impact the ever-shifting market dynamics • Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics • Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
